The University of Florida Department of Urology invites you to attend Grand Rounds:
Wednesday, February 8, 2023
7:00 am – 8:00 am
Urology Conference Room M2-203C
“Urinary Cytology and Biomarkers in the Diagnosis and Surveillance of Non-Muscle Invasive Bladder Cancer”
Hiroko Miyagi, MD
PGY 5
University of Florida
Department of Urology
LEARNING OBJECTIVES:
Upon completion of this activity, participants should be able to:
- Review the implications of atypical urine cytology
- Discuss the role of urinary biomarkers
- Review the role of Urovysion FISH in the evaluation of hematuria
- Review the role of Urovysion FISH as a predictor of response to treatment in NMIBC
Disclosure
Dr. Miyagi has disclosed that she has no relevant financial relationships. Planning committee member Vincent Bird, MD has disclosed that he is a consultant for Boston Scientific. No one else in a position to control content has any financial relationships to disclose. Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/. All relevant financial relationships have been mitigated.
Accreditation
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit
The University of Florida College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For additional information, contact Stephanie Stenner at 352/273-8634 or e-mail stephanie.stenner@urology.ufl.edu
Section # 2115
